Telomir Pharmaceuticals, Inc.
TELOFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Telomir Pharmaceuticals, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 4 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | 2026-03-31 | 35,795 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 121 | Not shown | SEC filing |
| Clearstead Advisors, LLC | 2026-03-31 | 12,530 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 206 | Not shown | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 36,061 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 10,411 | Not shown | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 51,454 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 249,086 | Not shown | SEC filing |
| Morton Capital Management LLC/CA | 2026-03-31 | 12,658 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 289,198 | Not shown | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 4 | Not shown | SEC filing |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 2026-03-31 | 11,000 | Not shown | SEC filing |
| Vestmark Advisory Solutions, Inc. | 2026-03-31 | 13,100 | Not shown | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 129,060 | Not shown | SEC filing |
| Suncoast Equity Management | 2026-03-31 | 51,194 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 9,213 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 58,600 | Not shown | SEC filing |
| OneDigital Investment Advisors LLC | 2026-03-31 | 23,000 | Not shown | SEC filing |
| REGIONS FINANCIAL CORP | 2026-03-31 | 10,638 | Not shown | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 2 | Not shown | SEC filing |
- Each value is checked against Telomir Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- NORTHERN TRUST CORP: 41,844 shares reported 2025-12-31; 41,844 shares reported 2026-03-31.
- Praetorian Wealth Management, Inc.: 10,000 shares reported 2025-12-31; 20,000 shares reported 2026-03-31.
- JONES FINANCIAL COMPANIES LLLP: 600 shares reported 2025-12-31; 600 shares reported 2026-03-31.
- REGIONS FINANCIAL CORP: 10,638 shares reported 2025-12-31; 10,638 shares reported 2026-03-31.
- OneDigital Investment Advisors LLC: 23,000 shares reported 2025-12-31; 23,000 shares reported 2026-03-31.
- STATE STREET CORP: 58,600 shares reported 2025-12-31; 58,600 shares reported 2026-03-31.
- UBS Group AG: 14,048 shares reported 2025-12-31; 9,213 shares reported 2026-03-31.
- Suncoast Equity Management: 51,194 shares reported 2025-12-31; 51,194 shares reported 2026-03-31.
- MILLENNIUM MANAGEMENT LLC: 166,975 shares reported 2025-12-31; 129,060 shares reported 2026-03-31.
- Vestmark Advisory Solutions, Inc.: 13,100 shares reported 2025-12-31; 13,100 shares reported 2026-03-31.
- KESTRA PRIVATE WEALTH SERVICES, LLC: 11,000 shares reported 2025-12-31; 11,000 shares reported 2026-03-31.
- SBI Securities Co., Ltd.: 4 shares reported 2025-12-31; 4 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
16 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-19 | Aminov Erez · CEO and Chairman | Common Stock | S — Open market or private sale | −200 | 6.01 | SEC filing |
| 2024-08-19 | Aminov Erez · CEO and Chairman | Common Stock | S — Open market or private sale | −200 | 6.20 | SEC filing |
| 2024-02-13 | Bay Shore Trust · 10% owner | Common Stock | P — Open market or private purchase | +49,000 | 7.00 | SEC filing |
| 2024-02-13 | Bay Shore Trust · 10% owner | Common Stock | P — Open market or private purchase | +40,000 | 7.00 | SEC filing |
Showing 4 of 4 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-21 | Whalen Matthew Pratt · Director | Incentive Stock Options (right to buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-05-21 | Aminov Erez · CEO and Chairman | Non-Qualified Stock Options (right to buy) | A — Grant, award, or other acquisition | +2,000,000 | SEC filing |
| 2026-05-21 | MacPherson Edward Clouston · Director | Incentive Stock Options (right to buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-05-21 | Aminov Erez · CEO and Chairman | Incentive Stock Options (right to buy) | A — Grant, award, or other acquisition | +1,960,170 | SEC filing |
| 2026-05-21 | Del Giudice Matthew Paul · Director | Incentive Stock Options (right to buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2025-05-28 | Aminov Erez · CEO and Chairman | Restricted Stock Units (RSUs) | A — Grant, award, or other acquisition | +400,000 | SEC filing |
| 2025-05-28 | Aminov Erez · CEO and Chairman | Non-Qualified Options | A — Grant, award, or other acquisition | +2,000,000 | SEC filing |
| 2024-11-21 | Bay Shore Trust · 10% owner | Common Stock (right to buy) | G — Bona fide gift | −100,000 | SEC filing |
Showing 8 of 11 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-21 | Aminov Erez · CEO and Chairman | Non-Qualified Stock Options (right to buy) | D — Disposition to the issuer | −2,000,000 | SEC filing |
| 2026-05-21 | Aminov Erez · CEO and Chairman | Incentive Stock Options (right to buy) | D — Disposition to the issuer | −1,960,170 | SEC filing |
| 2026-05-21 | MacPherson Edward Clouston · Director | Incentive Stock Options (right to buy) | D — Disposition to the issuer | −25,000 | SEC filing |
| 2026-05-21 | Del Giudice Matthew Paul · Director | Incentive Stock Options (right to buy) | D — Disposition to the issuer | −25,000 | SEC filing |
| 2026-05-21 | Whalen Matthew Pratt · Director | Incentive Stock Options (right to buy) | D — Disposition to the issuer | −25,000 | SEC filing |
| 2026-04-22 | Aminov Erez · CEO and Chairman | Common Stock | J — Other acquisition or disposition | +7,319,710 | SEC filing |
Showing 6 of 6 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.